Literature DB >> 24239650

IL-12hi rapamycin-conditioned dendritic cells mediate IFN-γ-dependent apoptosis of alloreactive CD4+ T cells in vitro and reduce lethal graft-versus-host disease.

Elizabeth O Stenger1, Brian R Rosborough2, Lisa R Mathews3, Huihui Ma4, Markus Y Mapara4, Angus W Thomson2, Hēth R Turnquist5.   

Abstract

Rapamycin (RAPA) inhibits the mechanistic target of rapamycin (mTOR), a crucial immune system regulator. Dendritic cells (DC) generated in RAPA (RAPA-DC) enrich for CD4(+) forkhead box p3 (FoxP3(+)) regulatory T cells and induce T cell apoptosis by an unknown mechanism. RAPA-DC also promote experimental allograft survival, yet paradoxically secrete increased IL-12, crucial for the generation of IFN-γ(+) CD4(+) T cells. However, IFN-γ is pro-apoptotic and IL-12-driven IFN-γ inhibits experimental graft-versus-host disease (GVHD). We hypothesized that IL-12(hi) RAPA-DC would facilitate IFN-γ-mediated apoptosis of alloreactive T cells and, unlike control (CTR)-DC, would reduce lethal GVHD. Following LPS stimulation, RAPA-DC exhibited decreased MHCII and co-stimulatory molecules and contained a significant population of CD86(lo) IL-12(hi) cells. Consistent with our hypothesis, both unstimulated and LPS-stimulated RAPA-DC enhanced alloreactive CD4(+) T cell apoptosis in culture. Augmented T cell apoptosis was ablated by IFN-γ neutralization or using T cells lacking the IFN-γ receptor, and it was associated with increased expression of Fas and cleaved caspase 8. DC production or responses to IFN-γ were not important to increased apoptotic functions of RAPA-DC. LPS-stimulated IL-12p40(-/-) RAPA-DC induced lower levels of T cell apoptosis in culture, which was further decreased with addition of anti-IFN-γ. Finally, whereas CTR-DC accelerated mortality from GVHD, LPS-treated RAPA-DC significantly prolonged host survival. In conclusion, increased apoptosis of allogeneic CD4(+) T cells induced by LPS-stimulated IL-12(hi) RAPA-DC is mediated in vitro through IFN-γ and in part by increased IL-12 expression. Enhanced production of IL-12, the predominant inducer of IFN-γ by immune cells, is a probable mechanism underlying the capacity of LPS-treated RAPA-DC to reduce GVHD.
Copyright © 2014 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Apoptosis; Dendritic cells; Graft-versus-host disease; IFN-γ; Rapamycin; T cells

Mesh:

Substances:

Year:  2013        PMID: 24239650      PMCID: PMC3964782          DOI: 10.1016/j.bbmt.2013.11.007

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  61 in total

1.  Interstitial pneumonitis associated with sirolimus therapy in renal-transplant recipients.

Authors:  S J Singer; R Tiernan; E J Sullivan
Journal:  N Engl J Med       Date:  2000-12-14       Impact factor: 91.245

Review 2.  Dendritic cells and regulation of graft-versus-host disease and graft-versus-leukemia activity.

Authors:  Elizabeth O Stenger; Hēth R Turnquist; Markus Y Mapara; Angus W Thomson
Journal:  Blood       Date:  2012-03-07       Impact factor: 22.113

3.  Dose and timing of interleukin (IL)-12 and timing and type of total-body irradiation: effects on graft-vs.-host disease inhibition and toxicity of exogenous IL-12 in murine bone marrow transplant recipients.

Authors:  M Sykes; D A Pearson; P A Taylor; G L Szot; S J Goldman; B R Blazar
Journal:  Biol Blood Marrow Transplant       Date:  1999       Impact factor: 5.742

4.  Enhanced allostimulatory activity of host antigen-presenting cells in old mice intensifies acute graft-versus-host disease.

Authors:  Rainer Ordemann; Raymond Hutchinson; Jeffrey Friedman; Steven J Burakoff; Pavan Reddy; Ulrich Duffner; Thomas M Braun; Chen Liu; Takanori Teshima; James L M Ferrara
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

5.  T cell apoptosis by tryptophan catabolism.

Authors:  F Fallarino; U Grohmann; C Vacca; R Bianchi; C Orabona; A Spreca; M C Fioretti; P Puccetti
Journal:  Cell Death Differ       Date:  2002-10       Impact factor: 15.828

6.  Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase.

Authors:  David H Munn; Madhav D Sharma; Jeffrey R Lee; Kanchan G Jhaver; Theodore S Johnson; Derin B Keskin; Brendan Marshall; Phillip Chandler; Scott J Antonia; Russell Burgess; Craig L Slingluff; Andrew L Mellor
Journal:  Science       Date:  2002-09-13       Impact factor: 47.728

7.  Mammalian target of rapamycin and glycogen synthase kinase 3 differentially regulate lipopolysaccharide-induced interleukin-12 production in dendritic cells.

Authors:  Masashi Ohtani; Shigenori Nagai; Shuhei Kondo; Shinta Mizuno; Kozue Nakamura; Masanobu Tanabe; Tsutomu Takeuchi; Satoshi Matsuda; Shigeo Koyasu
Journal:  Blood       Date:  2008-05-20       Impact factor: 22.113

8.  Interferon gamma is required for activation-induced death of T lymphocytes.

Authors:  Yosef Refaeli; Luk Van Parijs; Stephen I Alexander; Abul K Abbas
Journal:  J Exp Med       Date:  2002-10-07       Impact factor: 14.307

Review 9.  Dendritic cells and the promise of antigen-specific therapy in rheumatoid arthritis.

Authors:  Ranjeny Thomas
Journal:  Arthritis Res Ther       Date:  2013-02-04       Impact factor: 5.156

10.  Rapamycin impairs antigen uptake of human dendritic cells.

Authors:  Paolo Monti; Alessia Mercalli; Biagio Eugenio Leone; Di Carlo Valerio; Paola Allavena; Lorenzo Piemonti
Journal:  Transplantation       Date:  2003-01-15       Impact factor: 4.939

View more
  8 in total

1.  Complement C3a and C5a receptors promote GVHD by suppressing mitophagy in recipient dendritic cells.

Authors:  Hung Nguyen; Sandeepkumar Kuril; David Bastian; Jisun Kim; Mengmeng Zhang; Silvia G Vaena; Mohammed Dany; Min Dai; Jessica Lauren Heinrichs; Anusara Daenthanasanmak; Supinya Iamsawat; Steven Schutt; Jianing Fu; Yongxia Wu; David P Fairlie; Carl Atkinson; Besim Ogretmen; Stephen Tomlinson; Xue-Zhong Yu
Journal:  JCI Insight       Date:  2018-12-20

2.  Peri-alloHCT IL-33 administration expands recipient T-regulatory cells that protect mice against acute GVHD.

Authors:  Benjamin M Matta; Dawn K Reichenbach; Xiaoli Zhang; Lisa Mathews; Brent H Koehn; Gaelen K Dwyer; Jeremy M Lott; Franziska M Uhl; Dietmar Pfeifer; Colby J Feser; Michelle J Smith; Quan Liu; Robert Zeiser; Bruce R Blazar; Hēth R Turnquist
Journal:  Blood       Date:  2016-05-24       Impact factor: 22.113

3.  Anti-IL-22 Antibody Attenuates Acute Graft-versus-Host Disease via Increasing Foxp3+ T Cell through Modulation of CD11b+ Cell Function.

Authors:  Jianbo Wu; Jian Gu; Shun Zhou; Hao Lu; Yunjie Lu; Ling Lu; Xuehao Wang
Journal:  J Immunol Res       Date:  2018-08-07       Impact factor: 4.818

Review 4.  Regulation of Dendritic Cell Immune Function and Metabolism by Cellular Nutrient Sensor Mammalian Target of Rapamycin (mTOR).

Authors:  Julia P Snyder; Eyal Amiel
Journal:  Front Immunol       Date:  2019-01-14       Impact factor: 7.561

5.  Innate Immune Determinants of Graft-Versus-Host Disease and Bidirectional Immune Tolerance in Allogeneic Transplantation.

Authors:  Anouk A J Hamers; Sunil K Joshi; Asha B Pillai
Journal:  OBM Transplant       Date:  2019-01-31

6.  Cyclosporine A, in Contrast to Rapamycin, Affects the Ability of Dendritic Cells to Induce Immune Tolerance Mechanisms.

Authors:  Maja Machcińska; Monika Kotur; Aleksandra Jankowska; Marta Maruszewska-Cheruiyot; Artur Łaski; Zuzanna Kotkowska; Katarzyna Bocian; Grażyna Korczak-Kowalska
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2021-10-10       Impact factor: 4.291

7.  Rapamycin Alternatively Modifies Mitochondrial Dynamics in Dendritic Cells to Reduce Kidney Ischemic Reperfusion Injury.

Authors:  Maria Namwanje; Bijay Bisunke; Thomas V Rousselle; Gene G Lamanilao; Venkatadri S Sunder; Elizabeth C Patterson; Canan Kuscu; Cem Kuscu; Daniel Maluf; Manjari Kiran; Valeria Mas; James D Eason; Amandeep Bajwa
Journal:  Int J Mol Sci       Date:  2021-05-20       Impact factor: 5.923

Review 8.  Protein dysregulation in graft versus host disease.

Authors:  Liren Qian; Delia Dima; Cristian Berce; Yu Liu; Ioana Rus; Lajos-Zsolt Raduly; Yi Liu; Bobe Petrushev; Ioana Berindan-Neagoe; Alexandru Irimie; Alina Tanase; Ancuta Jurj; Jianliang Shen; Ciprian Tomuleasa
Journal:  Oncotarget       Date:  2017-12-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.